CSBR vs RUN · P/E 16, rev $56.9M vs P/E 6.0, rev $2.04B
Champions Oncology Inc (CSBR) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the CSBR and RUN stock pages for the full models.
Not investment advice.